Phenotypic analysis of 1-B-d-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response

This publication has 26 references indexed in Scilit:

• Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside
  Cancer Chemotherapy and Pharmacology, 1992
• Genetic Polymorphisms of Drug Metabolism
  Published by Elsevier ,1990
• Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia.
  Journal of Clinical Investigation, 1985
• The use of intermediate dose cytosine arabinoside (ID Ara‐C) in the treatment of acute non‐lymphocytic leukaemia in relapse
  British Journal of Haematology, 1984
• The relationship of Ara-C metabolism in vitro to therapeutic response in acute myeloid leukaemia
  Cancer Chemotherapy and Pharmacology, 1982
• Relationship between plasma Ara-C and intracellular Ara-CTP pools under conditions of continuous infusion and high-dose Ara-C treatment
  Medical and Pediatric Oncology, 1982
• Detection after electrophoresis of enzymes involved in ammonia metabolism using L-glutamate dehydrogenase as a linking enzyme
  Biochemical Genetics, 1977
• STUDIES ON MECHANISMS OF RESISTANCE TO CYTOSINE ARABINOSIDE: PROBLEMS IN THE DETERMINATION OF RELATED ENZYME ACTIVITIES IN LEUKEMIC CELLS
  Annals of the New York Academy of Sciences, 1975
• Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1968
• Studies of the enzymatic deamination of cytosine arabinoside—I
  Biochemical Pharmacology, 1965